Healthcare Chromatography Analyzers Market Report 2025

The healthcare chromatography analyzers market size has grown strongly in recent years. It will grow from $1.48 billion in 2024 to $1.56 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to several factors, including the rising prevalence of chronic diseases, an increased focus on analytical testing in hospitals, higher demand for quality control in biologics, greater utilization in clinical trials, and growing government funding for life sciences research.

The healthcare chromatography analyzers market size is expected to see strong growth in the next few years. It will grow to $1.9 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, a higher demand for high-throughput analyzers, expanding use in therapeutic drug monitoring, a growing focus on metabolomics and lipidomics, and rising demand for home-based diagnostic tools. Key trends in the forecast period include advancements in detector sensitivity, the development of custom chromatography solutions for targeted therapies, the integration of chromatography with mass spectrometry, the incorporation of lab automation systems, and innovations in column technology for faster analysis.

The rising prevalence of chronic diseases is expected to drive the growth of the healthcare chromatography analyzers market. Chronic diseases are long-lasting conditions that develop gradually and often require ongoing medical management. Inactive lifestyles, characterized by prolonged sitting and minimal physical activity, contribute to the growing incidence of conditions like heart disease and diabetes. Healthcare chromatography analyzers play a crucial role in improving diagnostic precision by enabling accurate biomolecular separation. These tools are vital for the early detection and tracking of biomarkers, ultimately enhancing disease management and patient outcomes in clinical environments. For example, in June 2024, the UK’s National Health Service reported that 3,615,330 individuals diagnosed with non-diabetic hyperglycemia or pre-diabetes were registered with a GP in 2023, marking an 18% increase from the previous year. This increase highlights the growing demand for healthcare chromatography analyzers as the prevalence of chronic diseases rises.

Leading companies in the healthcare chromatography analyzers market are developing next-generation products, such as high-performance liquid chromatography (HPLC) systems, to improve accuracy and efficiency in clinical diagnostics and pharmaceutical research. These advanced tools are designed to separate, identify, and quantify components in complex biological and pharmaceutical samples with high precision. For example, in April 2024, Waters Corporation launched the Alliance iS Bio HPLC System, a next-gen platform designed for biopharmaceutical quality control (QC) labs. The system features innovative MaxPeak high-performance surfaces (HPS) technology to minimize unwanted analyte interactions, and built-in intelligence, including an intuitive touchscreen interface and guided workflows, which reduce human error by up to 40%. These features provide faster, more reliable results, making the system an ideal choice for QC labs in the biopharma sector.

In January 2022, Bruker Corporation, a US-based scientific instruments company, acquired Prolab Instruments GmbH to enhance its liquid chromatography portfolio. This acquisition strengthens Bruker’s capabilities in single-cell and multi-omics workflows, particularly in the areas of proteomics and biomarker discovery. Prolab Instruments is a Switzerland-based company, specializes in nano- and micro-flow liquid chromatography systems tailored for healthcare applications.

Major players in the healthcare chromatography analyzers market are Hitachi Ltd., Merck and Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, GE Healthcare Life Sciences, Agilent Technologies Inc., Cytiva, PerkinElmer Inc., Shimadzu Corp, Waters Corp, Bio-Rad Laboratories Inc., Bruker Corp, Phenomenex Inc., Gilson Inc., Restek Corporation, Scion Instruments UK Ltd, Knauer GmbH, JASCO Corporation, E-Chrom Tech Co. Ltd., and SRI Instruments Inc.

North America was the largest region in the healthcare chromatography analyzers market in 2024. The regions covered in healthcare chromatography analyzers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the healthcare chromatography analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The healthcare chromatography analyzers market consists of sales of analytical columns, preparative columns, buffers, syringe filters, sample injectors, ultraviolet/visible detectors, and fluorescence detectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The healthcare chromatography analyzers market research report is one of a series of new reports that provides healthcare chromatography analyzers market statistics, including healthcare chromatography analyzers industry global market size, regional shares, competitors with a healthcare chromatography analyzers market share, detailed healthcare chromatography analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare chromatography analyzers industry. The healthcare chromatography analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare chromatography analyzers are sophisticated instruments designed to separate, identify, and quantify substances in complex biological samples, such as blood, urine, or tissue extracts. These devices are essential in clinical diagnostics, pharmaceutical analysis, and biomarker detection, ensuring precise and high-resolution analysis to aid in disease diagnosis, drug monitoring, and therapeutic research within healthcare environments.

The primary types of healthcare chromatography analyzers include supercritical fluid chromatography, thin-layer chromatography, gas chromatography, and liquid chromatography systems. Supercritical fluid chromatography utilizes supercritical fluids as the mobile phase, offering more efficient separations and faster analysis times compared to traditional liquid chromatography. The consumables and accessories for these systems include flow management components, detectors, fraction collectors, fittings, pressure regulators, column accessories, autosamplers, mobile phase materials, and columns. These analyzers are used by a broad range of industries and institutions, such as pharmaceutical and biotechnology companies, academic research labs, life sciences sectors, hospitals, food and beverage industries, and environmental agencies.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.